Cardlytics, Inc. (NASDAQ:CDLX) Receives $6.92 Consensus Target Price from Analysts

Shares of Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) have been given an average rating of "Hold" by the seven ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $6.92.

Several research firms have recently commented on CDLX. Craig Hallum raised shares of Cardlytics from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, November 6th. Needham & Company LLC reissued a "hold" rating on shares of Cardlytics in a research note on Thursday, November 7th. Finally, Evercore ISI started coverage on Cardlytics in a research note on Friday, October 11th. They set an "in-line" rating and a $4.00 price target on the stock.

Insider Activity

In related news, CEO Amit Gupta sold 22,607 shares of the firm's stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the sale, the chief executive officer now owns 178,519 shares of the company's stock, valued at approximately $687,298.15. This trade represents a 11.24 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Alexis Desieno sold 25,118 shares of the stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $3.43, for a total value of $86,154.74. Following the completion of the sale, the chief financial officer now owns 116,481 shares of the company's stock, valued at $399,529.83. This trade represents a 17.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cardlytics

Institutional investors and hedge funds have recently modified their holdings of the business. Atom Investors LP bought a new position in Cardlytics in the third quarter valued at approximately $33,000. SG Americas Securities LLC bought a new stake in Cardlytics in the 3rd quarter valued at $45,000. Intech Investment Management LLC acquired a new position in Cardlytics in the 3rd quarter worth $47,000. Quadrature Capital Ltd bought a new position in Cardlytics during the 3rd quarter worth about $63,000. Finally, BNP Paribas Financial Markets raised its stake in shares of Cardlytics by 32.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company's stock valued at $63,000 after purchasing an additional 4,796 shares during the period. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Price Performance

CDLX stock traded up $0.08 during midday trading on Friday, reaching $3.81. 1,077,758 shares of the company's stock traded hands, compared to its average volume of 800,779. The company has a 50-day simple moving average of $3.93 and a two-hundred day simple moving average of $4.85. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics has a 1-year low of $2.89 and a 1-year high of $20.52. The company has a market cap of $193.63 million, a price-to-earnings ratio of -0.62 and a beta of 1.53.

Cardlytics (NASDAQ:CDLX - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, beating analysts' consensus estimates of ($0.33) by $0.18. The company had revenue of $67.06 million during the quarter, compared to analyst estimates of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The firm's quarterly revenue was down 15.1% compared to the same quarter last year. During the same period last year, the company posted ($0.26) earnings per share. On average, analysts anticipate that Cardlytics will post -1.52 earnings per share for the current year.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.